Subgroup classification of receptor tyrosine kinase (RTK) pathway activation in KRAS-mutated metastatic carcinoma

被引:0
|
作者
Wang, Y. [1 ]
Windham, J. P. [1 ]
Samul, R. A. [1 ]
Sanidad, M. A. [1 ]
Farooqui, A. [1 ]
Gorman, B. M. [1 ]
Kelly, J. C. [1 ]
Meloni-Ehrig, A. M. [1 ]
Jones, D. [1 ]
机构
[1] Quest Diagnost Nichols Inst, Chantilly, VA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e18019
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Activation of the Akt-mTOR Pathway and Receptor Tyrosine Kinase in Patients With Solitary Fibrous Tumors
    Yamada, Yuichi
    Kohashi, Kenichi
    Fushimi, Fumiyoshi
    Takahashi, Yusuke
    Setsu, Nokitaka
    Endo, Makoto
    Yamamoto, Hidetaka
    Tokunaga, Shoji
    Iwamoto, Yukihide
    Oda, Yoshinao
    CANCER, 2014, 120 (06) : 864 - 876
  • [22] Overexpression and activation of the RON receptor tyrosine kinase in a panel of human colorectal carcinoma cell lines
    Chen, YQ
    Zhou, YQ
    Angeloni, D
    Kurtz, AL
    Qiang, XZ
    Wang, MH
    EXPERIMENTAL CELL RESEARCH, 2000, 261 (01) : 229 - 238
  • [23] Activation of the receptor protein tyrosine kinase EphB4 in endometrial hyperplasia and endometrial carcinoma
    Berclaz, G
    Karamitopoulou, E
    Mazzucchelli, L
    Rohrbach, V
    Dreher, E
    Ziemiecki, A
    Andres, AC
    ANNALS OF ONCOLOGY, 2003, 14 (02) : 220 - 226
  • [24] Activation of anaplastic lymphoma kinase receptor tyrosine kinase induces neuronal differentiation through the mitogen-activated protein kinase pathway
    Souttou, B
    Brunet-De Carvalho, N
    Raulais, D
    Vigny, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (12) : 9526 - 9531
  • [25] RECEPTOR-TYROSINE-KINASE-MEDIATED AND G-BETA-GAMMA-MEDIATED MAP KINASE ACTIVATION BY A COMMON SIGNALING PATHWAY
    VANBIESEN, T
    HAWES, BE
    LUTTRELL, DK
    KRUEGER, KM
    TOUHARA, K
    PORFIRI, E
    SAKAUE, M
    LUTTRELL, LM
    LEFKOWITZ, RJ
    NATURE, 1995, 376 (6543) : 781 - 784
  • [26] Wnt-5a-Receptor- Receptor Tyrosine Kinase-Like Orphan Receptor 2 Signaling Provokes Metastatic Colonization and Angiogenesis in Renal Cell Carcinoma, and Prunetin Supresses the Axis Activation
    Chuang, Wen-Yu
    Lee, Chao-Wei
    Fan, Wen-Lang
    Liu, Tsung-Ta
    Lin, Zih-Han
    Wang, Kuo-Chih
    Huang, Po-Jung
    Yeh, Yuan-Ming
    Lin, Tsung-Chieh
    AMERICAN JOURNAL OF PATHOLOGY, 2024, 194 (10): : 1967 - 1985
  • [27] A TYROSINE KINASE-DEPENDENT PATHWAY REGULATES LIGAND-DEPENDENT ACTIVATION OF THE DIOXIN RECEPTOR IN HUMAN KERATINOCYTES
    GRADIN, K
    WHITELAW, ML
    TOFTGARD, R
    POELLINGER, L
    BERGHARD, A
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (38) : 23800 - 23807
  • [28] Phase Ib/II study of the polo-like kinase 1 (PLK1) inhibitor, onvansertib, in combination with FOLFIRI and bevacizumab for second line treatment of KRAS-mutated metastatic colorectal cancer
    Ahn, D. H.
    Erlander, M.
    Ridinger, M.
    Samuelsz, E.
    Barzi, A.
    Bekaii-Saab, T.
    Lenz, H. J.
    ANNALS OF ONCOLOGY, 2020, 31 : S427 - S427
  • [29] Receptor tyrosine kinase pathway analysis sheds light on similarities between clear-cell sarcoma and metastatic melanoma
    Negri, Tiziana
    Brich, Silvia
    Conca, Elena
    Bozzi, Fabio
    Orsenigo, Marta
    Stacchiotti, Silvia
    Alberghini, Marco
    Mauro, Valentina
    Gronchi, Alessandro
    Dusio, Giuseppina F.
    Pelosi, Giuseppe
    Picci, Piero
    Casali, Paolo G.
    Pierotti, Marco A.
    Pilotti, Silvana
    GENES CHROMOSOMES & CANCER, 2012, 51 (02): : 111 - 126
  • [30] Receptor tyrosine kinase (RTK) signaling pathway in preclinical thyroid cancer models: Antitumor and antiangiogenic activity of lenvatinib to target VEGFR/FGFR/RET
    Tohyama, Osamu
    Matsui, Junji
    Kodama, Kotaro
    Sugi, Naoko Hata
    Kimura, Takayuki
    Okamoto, Kiyoshi
    Minoshima, Yukinori
    Iwata, Masao
    Funahashi, Yasuhiro
    CANCER RESEARCH, 2015, 75